Transition from a pure holding company structure to an operating holding company structure
First written in FY2016. 2 of 3 entries say "Cited as achieved", first in FY2017. Latest entry: FY2019.
5 other companies' latest entry also says "Cited as achieved".
- FY2019Cited as achievedAnnual report
「In addition, as part of the transition to a holding company structure, on 1 April 2009 the company carried out an absorption-type company split under which its pharmaceutical wholesale business was transferred to 東邦薬品株式会社 and the management business for its dispensing pharmacy operations was transferred to ファーマクラスター株式会社, with each company serving as an intermediate holding company.」
Cites the transition from a pure holding company structure to an operating holding company structure, together with the 2009 business transfers, as the background to the current group governance structure. - FY2017Cited as achievedAnnual report
「In addition, following the transition to a holding company structure, on 1 April 2009 we carried out an absorption-type company split under which our pharmaceutical wholesaling business was transferred to 東邦薬品株式会社 and the management business for our dispensing pharmacy operations was transferred to ファーマクラスター株式会社.」
Cites the transition to a holding company structure as part of the company's historical development, explaining the current structure of its operating companies and intermediate holding companies. - FY2016First statedAnnual report
「In June 2015, we transitioned from a pure holding company structure to an operating holding company structure in order to strengthen the group management structure and enhance the competitiveness of our group.」
The group management structure change implemented in June 2015 is described as a means of strengthening competitiveness.